David Southwell: CEO of Volastra Therapeutics

Feb. 28, 2026 Season: 8 Duration: 31:26 Episode: 88
Portrait of David Southwell

David Southwell, CEO of Volastra Therapeutics, shares his insights about leadership in biopharma and how Volastra is working to discover and develop oncology therapeutics targeting chromosomal instability, a vulnerability of cancers.

Alexion Patient portrait
Alexion Pharmaceuticals

Patient Videos
Bioasis Technologies

One in Six
Notable employee working in the lab.
Notable

Delivering the Right Drug to the Right Patient